Preparation method for Xeljanz related substance

A technology of tofacitinib and related substances, which is applied in the field of medicinal chemistry, can solve the problems of high cost and limited industrial application, and achieve the effects of simple operation, mild reaction conditions and high yield

Inactive Publication Date: 2018-02-16
JIANGSU QINGJIANG PHARMA
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation of key intermediate IV in this route uses sodium borohydride (easy to generate a lot of ga

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for Xeljanz related substance
  • Preparation method for Xeljanz related substance
  • Preparation method for Xeljanz related substance

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Add N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4 to a 250ml three-necked flask at 25°C -Amine hydrochloride (6.0g, 21.3mmol), add methanol (60ml), stir to dissolve, then add formic acid (2.2g, 32.0mmol), acetaldehyde (10.8g, 213mmol), then add NaBH in three batches 4 (1.6g, 42.6mmol), TLC (DCM:MeOH=10:1) after 1h reaction, the reaction was complete. The reaction solution was concentrated to dryness, water (60ml) and EA (60ml) were added to the concentrate, the layers were stirred, the water layer was extracted once with EA (60ml), the organic phase was combined, and 35% HCl / ethanol solution (12ml) was added , a large amount of solids were precipitated, the mixture was stirred at room temperature for 1 h, filtered, the filter cake was collected, and vacuum-dried at 45° C. for 16 h to obtain 5.1 g of white solids with a yield of 75.7%. 1 HNMR (DMSO- d6 , 400MHz) δ 12.97(brs, 1H), 11.46(br,1H), 8.49(s, 1H), 7.50(s, 1H), 6.94(s, 1H), 5.32(m, 1...

Embodiment 2

[0034] Add N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4 to a 250ml three-necked flask at 25°C -Amine hydrochloride (6.0g, 21.3mmol), add ethanol (60ml), stir to dissolve, then add acetic acid (2.2g, 32.0mmol), acetaldehyde (10.8g, 213mmol), then add NaBH in three batches 4 (1.6g, 42.6mmol), TLC (DCM:MeOH=10:1) after 1h reaction, the reaction was complete. Concentrate the reaction solution to dryness, add water (60ml) and EA (60ml) to the concentrate, stir and separate the layers, extract the water layer with EA (60ml) once more, combine the organic phases, add 35% HCl / ethanol solution (12ml) , a large amount of solids were precipitated, the mixture was stirred at room temperature for 1 h, filtered, the filter cake was collected, and vacuum-dried at 45°C for 16 h to obtain 4.5 g of white solids with a yield of 68.2%.

Embodiment 3

[0036] Add N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4 to a 250ml three-necked flask at 25°C -Amine hydrochloride (6.0g, 21.3mmol), add methanol (60ml), stir to dissolve, then add formic acid (1.47g, 32.0mmol), acetaldehyde (10.8g, 213mmol), then add NaBH in three batches 4 (1.6g, 42.6mmol), TLC (DCM:MeOH=10:1) after 1h reaction, the reaction was complete. Concentrate the reaction solution to dryness, add water (60ml) and EA (60ml) to the concentrate, stir and separate the layers, extract the water layer with EA (60ml) once more, combine the organic phases, add 35% HCl / ethanol solution (12ml) , a large amount of solids were precipitated, the mixture was stirred at room temperature for 1 h, filtered, the filter cake was collected, and vacuum-dried at 45°C for 16 h to obtain 4.8 g of white solids with a yield of 72.7%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method for a Xeljanz related substance. The preparation method is characterized by comprising the following steps: with N-methyl-N-((3R,4R)-4-methylpiperidine-3-yl)-7H-pyrrolo[2,3-d]pyrimidine-4-amine hydrochloride and acetaldehyde as starting materials, preparing N-((3R,4R)-1-ethyl-4-methylpiperidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine under the action of a reducing agent, and carrying out salification so as to obtain the Xeljanz related substance namely N-((3R,4R)-1-ethyl-4-methylpiperidine-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-amine hydrochloride as shown in a formula (I) which is described in the specification.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a method for preparing related substances of tofacitinib citrate, a medicine for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue, causing inflammation in the joints and surrounding tissues. Tofacitinib citrate is a drug for the treatment of rheumatoid arthritis developed by Pfizer Pharmaceuticals of the United States. Its trade name is Xeljanz. Adult patients with severely active rheumatoid arthritis (RA). [0003] Pfizer announced two preparation routes in patent WO2007012953 (see route 1 and route 2). The route shown in route 1 uses methyl (4-methylpyridin-3-yl) carbamate (compound I) as the starting material, first introduces a benzyl group to obtain compound II, and reduces II with sodium borohydride to obtain compound III. After chiral rhodium c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D487/04
CPCC07D487/04
Inventor 张勇陆俊周志慧陈光
Owner JIANGSU QINGJIANG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap